Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema

Acta Ophthalmologica

Volumn 90, Issue 2, 2012, Pages

  Penha, Fernando Marcondes ^a   Maia, Mauricio ^a   Cardillo, José Augusto ^a   Fernando Arevalo, J ^b   Wu, Lihteh ^c   Rodriguez, Francisco J ^d   Berrocal, María H ^e   Farah, Michel Eid ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Clinica Oftalmologica Centre Caracas   (Venezuela)

^c Instituto de Cirugia Ocular   (Costa Rica)

^d Fundacion Oftalmologica Nacional   (Colombia)

^e UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE;

ADULT; CASE CONTROL STUDY; CATARACT; CENTRAL MACULAR THICKNESS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DISEASE SEVERITY; DRUG SAFETY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84857792160     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.02098.x     Document Type: Letter

References (5)

1. Arevalo JF, Sanchez JG, Wu L, et al., (2009): Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Ophthalmology 116: 1488-1497.
2. Elman MJ, Aiello LP, Beck RW, et al., (2010): Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117: 1064-1077.
3. Folgosa MS, Messias A, Takata C, et al., (2010): Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation. Acta Ophthalmol 88: e297-e298.
4. Kreutzer TC, Al Saeidi R, Kook D, et al., (2010): Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema. Ophthalmologica 224: 258-264.
5. Maia M, Farah ME, Belfort RN, et al., (2007): Effects of intravitreal triamcinolone acetonide injection with and without preservative. Br J Ophthalmol 91: 1122-1124. (Pubitemid 47344879)